February 20, 2026
California’s pesticide testing framework is on the verge of its biggest recalibration in years. In mid‑2025, the California Department of Cannabis Control (DCC) opened rulemaking to modernize California cannabis pesticide action levels, updating pass/fail cutoffs and expanding what labs must test for—based on health‑based recommendations provided by the California Department of Pesticide Regulation (DPR).
For operators, labs, and investors, the practical impact is straightforward: Certificates of Analysis (COAs) will change, method validation targets (including limits of quantitation) may tighten, and recall/embargo risk can rise during the transition—especially for product types that concentrate residues.
This post summarizes what’s in the June 2025 proposal, why it matters operationally, and how to build a remediation and retesting playbook before the rules go live.
Informational only. This article is not legal advice and does not replace consulting your compliance counsel, QA leadership, and contract laboratories.
DCC’s rulemaking package titled “Pesticide Updates” (DCC‑2025‑03‑R) proposes to revise pesticide residue testing requirements in California. The headline is an overhaul of action levels—the regulatory thresholds that determine whether a batch passes or fails—intended to align with DPR’s health‑based analysis.
DCC published a Notice of Proposed Rulemaking Action: Pesticide Testing (dated May 23, 2025 and posted in June 2025) describing amendments to Title 4, Division 19 regulations and providing instructions for public comment participation. You can track the docket and download the rulemaking file here: https://www.cannabis.ca.gov/cannabis-laws/rulemaking/dcc-2025-03-r-pesticide-updates/
DPR’s technical foundation is laid out in its memorandum, “Recommended Revisions to the Pesticide Action Levels for Testing Cannabis Products in California” (December 18, 2024). That memo describes DPR’s evaluation approach and includes recommendations to revise action levels and expand the pesticide list. Source: https://cannabis.ca.gov/wp-content/uploads/sites/2/2025/06/dpr-memo-on-revised-action-levels-12-18-2024.pdf
In California’s compliance testing system, action levels are the measurement cutoffs used to determine regulatory compliance for pesticide residues.
Under existing rules, labs test for residual pesticides and report results on the COA. The relevant regulatory section for residual pesticide testing is commonly referenced as 4 CCR § 15719 (Residual Pesticides Testing). A convenient public copy is available at: https://www.law.cornell.edu/regulations/california/4-CCR-15719
When action levels change, you don’t just “update a spreadsheet.” You change:
One of DPR’s core recommendations was adding pesticides to the required testing list and revising action levels for a subset of existing analytes. Trade press and technical commentary on the proposal have referenced DPR’s recommendation to add 14 pesticides and revise action levels for 31 pesticides (exact counts and final numbers depend on the final adopted text). See DCC’s rulemaking file and related discussion: https://www.cannabissciencetech.com/view/public-comment-open-for-updated-cannabis-pesticide-testing-regulations-in-california
For compliance leaders, this means your historic “pass rate” may not be predictive once:
Most businesses experience pesticide regulation through their COA workflow: sampling, lab submission, results, and release decisions. DCC’s proposal is likely to drive changes in three COA‑adjacent areas: what is tested, how it’s reported, and how defensible the underlying method trail is.
Lower action levels can cause sudden increases in failures that look “unexpected” to non‑technical stakeholders. This is particularly true in product categories where manufacturing steps can concentrate residues relative to the starting material.
Even when a cultivation input passes historical thresholds, a new action level (or a newly required analyte) can change the release outcome for:
Your best defense is to identify which SKUs have the greatest exposure to the new cutoffs and build a prescreening plan before compliance testing is your first look.
California’s lab reporting is not just “provide a PDF.” Labs must generate COAs and upload them into the state’s track‑and‑trace environment on defined timelines.
The Certificate of Analysis rule is addressed in 4 CCR § 15726 (commonly accessed via regulatory databases). A publicly searchable summary excerpt is available here (access may vary): https://govt.westlaw.com/calregs/Document/I3D918690699E11EDB5569A0BCCCD916B
As thresholds shift, businesses should expect:
Your research notes correctly flag a likely operational outcome: a tighter audit trail. When regulators revise health‑based thresholds, the next question becomes whether lab methods and QA systems are robust enough to support enforcement.
From a practical standpoint, expect increased importance of:
Even if your organization never sees a lab audit, you will feel the downstream effects when distributors, retailers, or insurers demand cleaner documentation before accepting inventory.
The proposal’s regulatory intent is public health protection, but its biggest operational stressor will likely be laboratory method readiness.
Under current California rules, labs must establish limits of quantitation (LOQs) that meet regulatory expectations for residual pesticide testing (see 4 CCR § 15719). When action levels move lower, labs may need to:
For operators, the business risk is two‑sided:
DCC has shown that it is willing to standardize test methods to improve consistency across labs. For example, DCC implemented a standardized cannabinoid test method for certain categories beginning in 2024 (background on DCC’s lab program and testing resources): https://www.cannabis.ca.gov/licensees/testing-laboratories/
While pesticide methods are more complex, the direction of travel is similar: more consistency, more defensibility, less interpretive latitude.
If you use multiple contract labs, or if your distributors route compliance testing to different labs based on capacity, you should plan for inter‑lab variability—particularly for borderline results near action levels.
A practical near‑term mitigation is to:
California has increased emphasis on consumer protection through enforcement tools such as embargoes and recalls. When pass/fail thresholds tighten, enforcement outcomes can follow—not necessarily because operators became less careful, but because more product becomes non‑compliant by definition.
Industry reporting has highlighted that California regulators have used embargoes and recalls more actively in recent periods, especially where contamination risk is alleged. For context on enforcement activity, see coverage such as MJBizDaily’s reporting on embargoes and recalls (external industry source): https://mjbizdaily.com/news/california-issued-63-cannabis-recalls-nearly-500-product-embargoes-in-2024/401074/
During transitions, the most avoidable enforcement trigger is paperwork that doesn’t reflect the new reality:
If regulators or downstream partners suspect your documentation is “out of sync,” you can see product holds while facts are sorted.
The most useful way to manage the 2025 proposal is to treat it like a structured change‑control project that touches procurement, cultivation/manufacturing, QA, distribution, and lab vendor management.
Start with a simple objective: determine which finished goods are most likely to be affected by lower thresholds or newly required analytes.
Focus first on:
Deliverable to aim for: a ranked list of SKUs and inputs with an “impact likelihood” score and a plan to prescreen.
Where pesticide residues often enter the system is upstream—through cultivation inputs or ingredients you don’t fully control.
Tighten supplier management by:
For cultivation operators, use DPR’s resources on legal pesticide use criteria and vetted product lists as a compliance anchor: https://www.cdpr.ca.gov/cannabis-cultivation/
If your first look is the state compliance test, you’re letting a single event decide release, schedule, and sometimes the survival of a launch.
A practical approach:
Once new action levels arrive, borderline results become more common. Your retesting policy should be consistent, documented, and aligned with California’s rules and your distributor’s SOPs.
Include:
Your goal is not to “test until pass.” It is to run a defensible investigation process that supports accurate release decisions.
Your research notes highlight a common weak spot: teams understand pass/fail, but not always how action levels interact with batch definitions and sampling structure.
Cross‑training should cover:
When failures happen, the operators who can trace quickly and explain clearly reduce recall scope and shorten embargo windows.
Because this is a proposed rulemaking, the most important operational question is when the new action levels and pesticide list become enforceable—and whether DCC will provide any phase‑in or grace period.
Until DCC publishes final adopted text and an operative date, plan conservatively:
If a grace period is offered, treat it as an opportunity to stabilize—not as a reason to delay building internal controls.
Rulemaking timelines can move quickly, and implementation details matter. Use https://cannabisregulations.ai/ to track California regulatory updates, translate new testing requirements into operational SOPs, and maintain a defensible cannabis compliance program across suppliers, labs, distributors, and retail partners.
